Full Year 2025 Aevis Victoria SA Earnings Call Transcript
Key Points
- Aevis Victoria SA (XSWX:AEVS) reported a 13.5% increase in turnover for 2025, driven by strategic acquisitions.
- The company's NAV per share increased by 7.8%, indicating continued value creation.
- The hospitality segment showed strong performance with organic growth of 4.5% and improved EBITDAR margins.
- The healthcare segment, particularly Swiss Medical Network, achieved a 22% revenue growth due to acquisitions.
- Aevis Victoria SA (XSWX:AEVS) successfully reduced its leverage ratio from 53.4% to 49.9%, reflecting strong debt management.
- EBITDA declined due to the absence of profits from previous sales of participations.
- The healthcare segment experienced a slight decline in EBITDAR margins from 16.6% to 15.9%.
- The ambulatory segment, a strategic investment, currently operates at a low margin of 6.6%, diluting overall margins.
- The ventures and start-up operations segment remains loss-making, detracting CHF 11 million from EBITDA.
- The company faces challenges in the healthcare market, including escalating costs and an aging population.
Thank you very much. Welcome to the presentation of 2025 annual results. We just published our annual report this morning. And I'm here with Fabrice Zumbrunnen, CEO of Aevis Victoria; and Michel Keusch, CFO of Aevis Victoria. As you know, Aevis Victoria is an investment company and focusing on service to people.
Our investments, if you take a look at this slide, our main investments, Swiss Medical Network and VIVA, our insurance product that we have with Visana. They represent 59% of the investment. MRH Switzerland, our hospitality, and Batmaid represents 19% of our investment. And infrastructure, so our 30% shareholding into Infracore, and Swiss Hotel Properties represents 22% of our investment.
This year 2025, if we can highlight some event, it was the takeover in December 2024 of Spital Zofingen. This was the fourth public hospital that Swiss Medical Network has acquired. The first one was in 2012, Hopital de La Providence in Neuch'tel, and then with Hopital Generale Beaulieu, the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
